Alkyl Amines Chemicals Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 2 Jun 2026 | Chemicals & Petrochemicals | Market Cap: ₹9.9K Cr
The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9). The company expects a cautious optimism for future growth, with better times ahead after recent challenges.
From Alkyl Amines Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹2,053
Market Cap
₹9.9K Cr
P/E Ratio
44.1
Revenue Rank
Margin Rank
How does Alkyl Amines Chemicals Ltd rank in Chemicals & Petrochemicals?
Compare Alkyl Amines Chemicals Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Alkyl Amines Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹387 Cr, net profit ₹45 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 4- →The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9).
- →FY26 volume was essentially flat, with minor fluctuations (±1%) (Page 7).
- →The company anticipates normal growth rates around 5-10% going forward, assuming market conditions stabilize (Pages 6-7).
- →Capacity utilization across plants is currently between 60% to 85%, with sufficient capacity for the next few years without major new investments (Page 12).
- →Ethylamines have sufficient capacity for the next 4-5 years; methylamines currently face some overcapacity (Page 10).
- →Price increases due to raw material cost hikes may persist; margins are expected to improve but with some caution due to market uncertainties (Pages 8-9).
- →The company maintains cautious optimism for better growth compared to past challenging years (Page 8).
📈 Profitability & Margins
Rank 2- →The company expects a cautious optimism for future growth, with better times ahead after recent challenges.
- →Volume growth is anticipated at around 5% to 10% annually, aligned with overall country growth.
- →Prices have increased due to raw material cost pressures, with finished product prices unlikely to return to pre-February levels soon.
- →Margins in ethylamines have improved and are stable; methylamines face competition and overcapacity, potentially impacting margins.
- →New product launches from R&D are expected, but capital investment will depend on market stability and long-term profitability.
- →Capacity utilization is healthy (60%-85%) with sufficient capacity for existing products for the next 4-5 years without major capex.
- →Green ammonia and alternative raw materials are being monitored as future inputs but likely 3-5 years away.
- →Impact from reduced Chinese competition is expected to help margins moderately.
🏗️ Capital Expenditure Plans
Yes- →Current capex includes completion of an ongoing new product plant at Dahej and some engineering projects, estimated around INR 80 to 90 crores for FY27 and FY28.
- →No major new projects or product plants are planned immediately beyond the existing ones.
- →Maintenance capex is ongoing in the range of INR 20 to 30 crores annually.
- →Potential capex may arise if some R&D products currently in the pipeline progress to commercialization, but this is dependent on market stability and final investment decisions.
- →The company is cautious about large investments amid market volatility and raw material uncertainties.
- →Overall, no significant aggressive capex announced for near term; focus is on completing current projects and monitoring new product viability before committing further.
💰 Fundraising & Capital Structure
No- →There is no mention of any major new fundraising through debt or equity in the current discussion.
- →The company is cautious about investments given market volatility.
- →Planned capex for FY27 and FY28 is around INR 80-90 crores, mainly to complete existing projects and some engineering works.
- →No new large projects or significant capex are planned at present, but capex may arise if some R&D products proceed to commercialization.
- →The company appears to focus on completing ongoing projects and maintenance capex (around INR 20-30 crores).
- →No explicit indication of raising funds via debt or equity has been disclosed during the call.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Alkyl Amines Chemicals Ltd Q4 FY26 results?
The company expects volume growth of about 5% to 10% annually, aligned with overall country growth (Page 9). The company expects a cautious optimism for future growth, with better times ahead after recent challenges.
What is Alkyl Amines Chemicals Ltd share price analysis?
Alkyl Amines Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 44.1 with a market cap of ₹9,921 Cr. Investors should review the full earnings analysis for detailed insights.
Is Alkyl Amines Chemicals Ltd planning capital expenditure?
Current capex includes completion of an ongoing new product plant at Dahej and some engineering projects, estimated around INR 80 to 90 crores for FY27 and FY28.
Keep Alkyl Amines Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.